Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double-blind randomized trial.
Borhannejad F, Shariati B, Naderi S, Shalbafan M, Mortezaei A, Sahebolzamani E, Saeb A, Hosein Mortazavi S, Kamalzadeh L, Aqamolaei A, Ali Noorbala A, Namazi-Shabestari A, Akhondzadeh S. Borhannejad F, et al. Among authors: naderi s. J Clin Pharm Ther. 2020 Aug;45(4):804-811. doi: 10.1111/jcpt.13177. Epub 2020 May 18. J Clin Pharm Ther. 2020. PMID: 32420649 Clinical Trial.
Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study.
Baziar S, Aqamolaei A, Khadem E, Mortazavi SH, Naderi S, Sahebolzamani E, Mortezaei A, Jalilevand S, Mohammadi MR, Shahmirzadi M, Akhondzadeh S. Baziar S, et al. Among authors: naderi s. J Child Adolesc Psychopharmacol. 2019 Apr;29(3):205-212. doi: 10.1089/cap.2018.0146. Epub 2019 Feb 11. J Child Adolesc Psychopharmacol. 2019. PMID: 30741567 Clinical Trial.
L-Carnosine combination therapy for major depressive disorder: A randomized, double-blind, placebo-controlled trial.
Araminia B, Shalbafan M, Mortezaei A, Shirazi E, Ghaffari S, Sahebolzamani E, Mortazavi SH, Shariati B, Ardebili ME, Aqamolaei A, Naderi S, Akhondzadeh S. Araminia B, et al. Among authors: naderi s. J Affect Disord. 2020 Apr 15;267:131-136. doi: 10.1016/j.jad.2020.02.020. Epub 2020 Feb 7. J Affect Disord. 2020. PMID: 32063564 Clinical Trial.
5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control.
Yousefzadeh F, Sahebolzamani E, Sadri A, Mortezaei A, Aqamolaei A, Mortazavi SH, Shalbafan MR, Ghaffari S, Alikhani R, Mousavi SB, Naderi S, Shamabadi A, Jalilevand S, Akhondzadeh S. Yousefzadeh F, et al. Among authors: naderi s. Int Clin Psychopharmacol. 2020 Sep;35(5):254-262. doi: 10.1097/YIC.0000000000000321. Int Clin Psychopharmacol. 2020. PMID: 32541380 Clinical Trial.
Levetiracetam adjunct to quetiapine for the acute manic phase of bipolar disorder: a randomized, double-blind and placebo-controlled clinical trial of efficacy, safety and tolerability.
Zarezadeh F, Arbabi M, Shamabadi A, Naderi S, Hasanzadeh A, Ostadpour M, Samsami FS, Akhondzadeh S. Zarezadeh F, et al. Among authors: naderi s. Int Clin Psychopharmacol. 2022 Mar 1;37(2):46-53. doi: 10.1097/YIC.0000000000000383. Int Clin Psychopharmacol. 2022. PMID: 34864756 Clinical Trial.
A Rapid Host Response Blood Test for Bacterial/Viral Infection Discrimination Using a Portable Molecular Diagnostic Platform.
Iglesias-Ussel MD, O'Grady N, Anderson J, Mitsis PG, Burke TW, Henao R, Scavetta J, Camilleri C, Naderi S, Carittini A, Perelman M, Myers RA, Ginsburg GS, Ko ER, McClain MT, van Westrienen J, Tsalik EL, Tillekeratne LG, Woods CW. Iglesias-Ussel MD, et al. Among authors: naderi s. Open Forum Infect Dis. 2024 Dec 11;12(1):ofae729. doi: 10.1093/ofid/ofae729. eCollection 2025 Jan. Open Forum Infect Dis. 2024. PMID: 39758742 Free PMC article.
404 results